45 CFR § 180 compliance
C · 70
This hospital published part of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
4,798
Insurances with rates
2
CPT / HCPCS codes
3,391
Source MRF
Most expensive procedures (gross)
J3399
$2,163,400
Onasemnogene Abeparvovec-xioi 7x8.3 ML Susp Kit
Gross
$2,704,250
Q2056
$1,611,182
CILTACABTAGENE AUTOLEUCEL
Gross
$2,013,978
Q2054
$1,571,600
LISOCABTAGENE MARALEUCEL
Gross
$1,964,500
Q2041
$1,546,197
AXICABTAGENE CILOLEUCEL
Gross
$1,932,746
Q2055
$1,532,850
IDECABTAGENE VICLEUCEL
Gross
$1,916,063
Q2042
$1,473,667
TISAGENLECLEUCEL CAR POS T LYMPHOMA ADULTS
Gross
$1,842,084
Q2053
$1,418,535
BREXUCABTAGENE AUTOLEUCEL
Gross
$1,773,169
C9482
$114,699
Sotalol HCl Inj 150 MG/10ML (15 MG/ML)
Gross
$143,374
J9226
$72,648
Histrelin Acetate (CPP) Implant Kit 50 MG
Gross
$90,810
0811
$59,173
LIVE DONOR KIDNEY ACQUIS
Gross
$73,966
0812
$59,173
KIDNEY STANDARD ACQUIS
Gross
$73,966
C1827
$56,640
IPG VNS VIVISTIM
Gross
$70,800
33264
$55,643
RMVL & REPLC DEFIB GEN MULT LEADS
Gross
$69,554
L8614
$53,088
COCHLEAR NUCLEUS CI512
Gross
$66,360
0408T
$52,243
INSJ/RPLC CAR MODULJ SYS PLS GEN TRANSVNS ELTRD
Gross
$65,304
C1820
$48,000
STIM DBS ACTIVA RC RECHG
Gross
$60,000
J3316
$47,360
Triptorelin Pamoate For IM ER Susp 22.5 MG (Base Equiv)
Gross
$59,200
J9118
$46,690
Calaspargase Pegol-mknl IV Soln 3750 Unit/5ML (750 Unit/ML)
Gross
$58,363
C9293
$46,172
Glucarpidase For IV Inj 1000 UNIT
Gross
$57,715
33231
$45,630
INSERT DEFIB GENERATOR W EXIST MULT LEADS
Gross
$57,038
C2624
$43,200
KT PA CARDIOMEM SENSOR DEL SYS
Gross
$54,000
C1822
$41,691
SYS STIM SPNL SENZA IPG
Gross
$52,114
J2326
$41,667
Nusinersen Intrathecal Soln 12 MG/5ML (2.4 MG/ML)
Gross
$52,083
J9266
$41,065
Pegaspargase Inj 750 Unit/ML
Gross
$51,332
J9229
$40,704
Inotuzumab Ozogamicin For IV Soln 0.9 MG
Gross
$50,880
33263
$38,720
RMVL & REPLC DEFIB GEN DUAL LEADS
Gross
$48,400
J2502
$38,653
Pasireotide Pamoate For IM ER Susp 20 MG (Base Equiv)
Gross
$48,316
C1826
$38,400
STIM NEURO GENRTR INCEPTIV SCS
Gross
$48,000
C2616
$37,407
Y90 BRACYTX NONSTRANDED PER SOURCE
Gross
$46,759
33262
$37,282
RMVL & REPLC DEFIB GEN SNGLE LEAD
Gross
$46,603
J9348
$35,278
Naxitamab-gqgk IV Soln 40 MG/10ML (4 MG/ML)
Gross
$44,097
0571T
$35,139
INSJ/RPLCMT ICDS W/SUBSTERNAL ELECTRODE
Gross
$43,924
C1735
$34,960
CATH RDN SYMPLICITY SPYRAL 4FR
Gross
$43,700
C9767
$34,768
REVASC LITHOTRIP-STENT-ATHER
Gross
$43,460
37294
$34,257
SURG 37294 REVSC EVASC TPVT ST ATHRC UNI CPLX LES 1ST VSL
Gross
$42,821
37277
$34,062
SURG 37277 REVSC EVASC FPVT ST ATHRC UNI CPLX LES 1ST VSL
Gross
$42,577
93653
$32,051
COMPRE EP EVAL ABLTJ 3D MAPG TX SVT
Gross
$40,064
33240
$31,942
INSERT DEFIB GENERATOR W EXIST SNGLE LEAD
Gross
$39,927
37292
$31,857
SURG 37292 REVSC EVASC TPVT ST ATHRC UNI SF LES 1ST VSL
Gross
$39,821
C1882
$31,692
CRT-D UNIFY ASSURA DF4
Gross
$39,615
37275
$31,662
SURG 37275 REVSC EVASC FPVT ST ATHRC UNI SF LES 1ST VSL
Gross
$39,577
93654
$31,070
COMPRE EP EVAL ABLTJ 3D MAPG TX VT
Gross
$38,838
33230
$31,038
INSERT DEFIB GENERATOR W EXIST DUAL LEADS
Gross
$38,797
93656
$30,374
COMPRE EP EVAL ABLTJ ATR FIB PULM VEIN ISOLATION
Gross
$37,967
37290
$28,120
SURG 37290 REVSC EVASC TPVT ATHRC UNI CPLX LES 1ST VSL
Gross
$35,150
C9797
$27,534
VASC EMB OR OCC W PRS CATH INCL IMAGING
Gross
$34,417
0569T
$27,192
SURG 0569T TRANSCATH TRICUSPID VALVE RPR PERQ INIT PROSTH
Gross
$33,990
34843
$27,101
SURG 34843 ENDOVASC VISCER AORTA REPAIR FENEST 3 ENDOGRAFT
Gross
$33,876
C9765
$26,919
REVASC INTRA LITHOTRIP-STENT
Gross
$33,649
C9766
$26,846
REVASC INTRA LITHOTRIP-ATHER
Gross
$33,557
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J3399 | Onasemnogene Abeparvovec-xioi 7x8.3 ML Susp Kit | $2,704,250 | $2,163,400 | — | — | 2 |
| Q2056 | CILTACABTAGENE AUTOLEUCEL | $2,013,978 | $1,611,182 | — | — | 2 |
| Q2054 | LISOCABTAGENE MARALEUCEL | $1,964,500 | $1,571,600 | — | — | 2 |
| Q2041 | AXICABTAGENE CILOLEUCEL | $1,932,746 | $1,546,197 | — | — | 2 |
| Q2055 | IDECABTAGENE VICLEUCEL | $1,916,063 | $1,532,850 | — | — | 2 |
| Q2042 | TISAGENLECLEUCEL CAR POS T LYMPHOMA ADULTS | $1,842,084 | $1,473,667 | — | — | 2 |
| Q2053 | BREXUCABTAGENE AUTOLEUCEL | $1,773,169 | $1,418,535 | — | — | 2 |
| C9482 | Sotalol HCl Inj 150 MG/10ML (15 MG/ML) | $143,374 | $114,699 | — | — | 2 |
| J9226 | Histrelin Acetate (CPP) Implant Kit 50 MG | $90,810 | $72,648 | — | — | 2 |
| 0811 | LIVE DONOR KIDNEY ACQUIS | $73,966 | $59,173 | — | — | 2 |
| 0812 | KIDNEY STANDARD ACQUIS | $73,966 | $59,173 | — | — | 2 |
| C1827 | IPG VNS VIVISTIM | $70,800 | $56,640 | — | — | 2 |
| 33264 | RMVL & REPLC DEFIB GEN MULT LEADS | $69,554 | $55,643 | — | — | 2 |
| L8614 | COCHLEAR NUCLEUS CI512 | $66,360 | $53,088 | — | — | 2 |
| 0408T | INSJ/RPLC CAR MODULJ SYS PLS GEN TRANSVNS ELTRD | $65,304 | $52,243 | — | — | 2 |
| C1820 | STIM DBS ACTIVA RC RECHG | $60,000 | $48,000 | — | — | 2 |
| J3316 | Triptorelin Pamoate For IM ER Susp 22.5 MG (Base Equiv) | $59,200 | $47,360 | — | — | 2 |
| J9118 | Calaspargase Pegol-mknl IV Soln 3750 Unit/5ML (750 Unit/ML) | $58,363 | $46,690 | — | — | 2 |
| C9293 | Glucarpidase For IV Inj 1000 UNIT | $57,715 | $46,172 | — | — | 2 |
| 33231 | INSERT DEFIB GENERATOR W EXIST MULT LEADS | $57,038 | $45,630 | — | — | 2 |
| C2624 | KT PA CARDIOMEM SENSOR DEL SYS | $54,000 | $43,200 | — | — | 2 |
| C1822 | SYS STIM SPNL SENZA IPG | $52,114 | $41,691 | — | — | 2 |
| J2326 | Nusinersen Intrathecal Soln 12 MG/5ML (2.4 MG/ML) | $52,083 | $41,667 | — | — | 2 |
| J9266 | Pegaspargase Inj 750 Unit/ML | $51,332 | $41,065 | — | — | 2 |
| J9229 | Inotuzumab Ozogamicin For IV Soln 0.9 MG | $50,880 | $40,704 | — | — | 2 |
| 33263 | RMVL & REPLC DEFIB GEN DUAL LEADS | $48,400 | $38,720 | — | — | 2 |
| J2502 | Pasireotide Pamoate For IM ER Susp 20 MG (Base Equiv) | $48,316 | $38,653 | — | — | 2 |
| C1826 | STIM NEURO GENRTR INCEPTIV SCS | $48,000 | $38,400 | — | — | 2 |
| C2616 | Y90 BRACYTX NONSTRANDED PER SOURCE | $46,759 | $37,407 | — | — | 2 |
| 33262 | RMVL & REPLC DEFIB GEN SNGLE LEAD | $46,603 | $37,282 | — | — | 2 |
| J9348 | Naxitamab-gqgk IV Soln 40 MG/10ML (4 MG/ML) | $44,097 | $35,278 | — | — | 2 |
| 0571T | INSJ/RPLCMT ICDS W/SUBSTERNAL ELECTRODE | $43,924 | $35,139 | — | — | 2 |
| C1735 | CATH RDN SYMPLICITY SPYRAL 4FR | $43,700 | $34,960 | — | — | 2 |
| C9767 | REVASC LITHOTRIP-STENT-ATHER | $43,460 | $34,768 | — | — | 2 |
| 37294 | SURG 37294 REVSC EVASC TPVT ST ATHRC UNI CPLX LES 1ST VSL | $42,821 | $34,257 | — | — | 2 |
| 37277 | SURG 37277 REVSC EVASC FPVT ST ATHRC UNI CPLX LES 1ST VSL | $42,577 | $34,062 | — | — | 2 |
| 93653 | COMPRE EP EVAL ABLTJ 3D MAPG TX SVT | $40,064 | $32,051 | — | — | 2 |
| 33240 | INSERT DEFIB GENERATOR W EXIST SNGLE LEAD | $39,927 | $31,942 | — | — | 2 |
| 37292 | SURG 37292 REVSC EVASC TPVT ST ATHRC UNI SF LES 1ST VSL | $39,821 | $31,857 | — | — | 2 |
| C1882 | CRT-D UNIFY ASSURA DF4 | $39,615 | $31,692 | — | — | 2 |
| 37275 | SURG 37275 REVSC EVASC FPVT ST ATHRC UNI SF LES 1ST VSL | $39,577 | $31,662 | — | — | 2 |
| 93654 | COMPRE EP EVAL ABLTJ 3D MAPG TX VT | $38,838 | $31,070 | — | — | 2 |
| 33230 | INSERT DEFIB GENERATOR W EXIST DUAL LEADS | $38,797 | $31,038 | — | — | 2 |
| 93656 | COMPRE EP EVAL ABLTJ ATR FIB PULM VEIN ISOLATION | $37,967 | $30,374 | — | — | 2 |
| 37290 | SURG 37290 REVSC EVASC TPVT ATHRC UNI CPLX LES 1ST VSL | $35,150 | $28,120 | — | — | 2 |
| C9797 | VASC EMB OR OCC W PRS CATH INCL IMAGING | $34,417 | $27,534 | — | — | 2 |
| 0569T | SURG 0569T TRANSCATH TRICUSPID VALVE RPR PERQ INIT PROSTH | $33,990 | $27,192 | — | — | 2 |
| 34843 | SURG 34843 ENDOVASC VISCER AORTA REPAIR FENEST 3 ENDOGRAFT | $33,876 | $27,101 | — | — | 2 |
| C9765 | REVASC INTRA LITHOTRIP-STENT | $33,649 | $26,919 | — | — | 2 |
| C9766 | REVASC INTRA LITHOTRIP-ATHER | $33,557 | $26,846 | — | — | 2 |
Showing top 50 of 4,798 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.